"The highest quality in clinical trials. Our goal is to help science advance and help patients in need."

During the past decade, InvesClinic, LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "InvesClinic, LLC" #1 sponsor was "Pfizer" with 4 trials, followed by "Arrowhead Pharmaceuticals" with 3 trials sponsored, "Abbott Nutrition" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Bill & Melinda Gates Medical Research Institute" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "InvesClinic, LLC" #1 collaborator was "United States Department of Defense" with 2 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "Integrium" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "InvesClinic, LLC" are "COVID-19" (2 trials), "Cardiovascular Disease" (2 trials), "Covid19" (2 trials), "Hyperlipidemia" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "InvesClinic, LLC" in a lesser frequency.

Most popular intervention types in "InvesClinic, LLC" are "Drug" (12 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "ARO-APOC3" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "Bococizumab 150mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "InvesClinic, LLC" are 16 trials for "All" genders.

Currently, there are NaN active trials in "InvesClinic, LLC". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in InvesClinic, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in InvesClinic, LLC, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".